Orchard Park Pediatrics Pc

CLIA Laboratory Citation Details

2
Total Citations
13
Total Deficiencyies
7
Unique D-Tags
CMS Certification Number 33D0682685
Address 3725 North Buffalo Road, Suite A, Orchard Park, NY, 14127
City Orchard Park
State NY
Zip Code14127
Phone716 662-2300
Lab DirectorKATHLEEN DYSON

Citation History (2 surveys)

Survey - November 21, 2024

Survey Type: Standard

Survey Event ID: 5U6V11

Deficiency Tags: D5217 D6015 D5217 D6015 D2000

Summary:

Summary Statement of Deficiencies D2000 ENROLLMENT AND TESTING OF SAMPLES CFR(s): 493.801 Each laboratory must enroll in a proficiency testing (PT) program that meets the criteria in subpart I of this part and is approved by HHS. The laboratory must enroll in an approved program or programs for each of the specialties and subspecialties for which it seeks certification. The laboratory must test the samples in the same manner as patients' specimens. For laboratories subject to 42 CFR part 493 published on March 14, 1990 (55 FR 9538) prior to September 1, 1992, the rules of this subpart are effective on September 1, 1992. For all other laboratories, the rules of this subpart are effective January 1, 1994. This CONDITION is not met as evidenced by: Based on review of Centers for Medicare & Medicaid Services (CMS) Proficiency Testing (PT) Certification and Survey Provider Enhanced Reporting system (CASPER 0096D) and College of American Pathologists (CAP) PT summary reports, Standard Operating Procedures (SOPs), as well as interviews with the Laboratory Director (LD) and Testing Personnel (TP), the laboratory failed to enroll in a PT program for the bacteriology subspecialty. FINDINGS: 1. There was no documentation of 2024 PT enrollment, performance, and result reporting for the bacteriology subspecialty. 2. It was noted that documentation was available for 2022 and 2023 PT bacteriology subspecialty enrollment, performance, and result reporting. 3. The current, approved SOPs did not include instructions for performing bacteriology subspecialty PT and result reporting. 4. The LD and TP confirmed the findings on November 21, 2024, at approximately 10:30 A.M. D5217 EVALUATION OF PROFICIENCY TESTING PERFORMANCE CFR(s): 493.1236(c)(1) Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- At least twice annually, the laboratory must verify the accuracy of any test or procedure it performs that is not included in subpart I of this part. This STANDARD is not met as evidenced by: Based on review of laboratory records and SOPs, lack of urine culture colony count verification documentation, as well as interviews with the LD and TP, the laboratory failed to establish and maintain the accuracy of its testing procedures. FINDINGS: 1. There was no documentation of minimum twice annual urine culture colony count verifications for 2023 and 2024. 2. It was noted that documentation was available for 2022 twice annual urine culture colony count verifications. 3. The current, approved SOPs do not include instructions for performing such activity. 4. The LD and TP confirmed the findings on November 21, 2024, at approximately 10:00 A.M. D6015 LABORATORY DIRECTOR RESPONSIBILITIES CFR(s): 493.1407(e)(4) The laboratory director is responsible for the overall operation and administration of the laboratory, including the employment of personnel who are competent to perform test procedures, and record and report test results promptly, accurate, and proficiently and for assuring compliance with the applicable regulations. (e) The laboratory director must-- (e)(4) Ensure that the laboratory is enrolled in an HHS approved proficiency testing program for the testing performed. This STANDARD is not met as evidenced by: Based on CMS PT CASPER 0096D and CAP PT summary reports from 2024, SOPs, as well as interviews with the LD and TP, the LD failed to ensure that the laboratory was enrolled in a PT program for the bacteriology subspecialty. Refer to D2000. -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - October 9, 2020

Survey Type: Special

Survey Event ID: 25FE11

Deficiency Tags: D2016 D2021 D6000 D6016 D2016 D2021 D6000 D6016

Summary:

Summary Statement of Deficiencies D2016 SUCCESSFUL PARTICIPATION CFR(s): 493.803(a)(b)(c) (a) Each laboratory performing nonwaived testing must successfully participate in a proficiency testing program approved by CMS, if applicable, as described in subpart I of this part for each specialty, subspecialty, and analyte or test in which the laboratory is certified under CLIA. (b) Except as specified in paragraph (c) of this section, if a laboratory fails to participate successfully in proficiency testing for a given specialty, subspecialty, analyte or test, as defined in this section, or fails to take remedial action when an individual fails gynecologic cytology, CMS imposes sanctions, as specified in subpart R of this part. (c) If a laboratory fails to perform successfully in a CMS- approved proficiency testing program, for the initial unsuccessful performance, CMS may direct the laboratory to undertake training of its personnel or to obtain technical assistance, or both, rather than imposing alternative or principle sanctions except when one or more of the following conditions exists: (1) There is immediate jeopardy to patient health and safety. (2) The laboratory fails to provide CMS or a CMS agent with satisfactory evidence that it has taken steps to correct the problem identified by the unsuccessful proficiency testing performance. (3) The laboratory has a poor compliance history. This CONDITION is not met as evidenced by: Based on proficiency testing (PT) desk review of the Center for Medicare and Medicaid Services (CMS) PT data reports and PT records from the College of American Pathologists (CAP) PT program, the laboratory failed to participate successfully in proficiency testing for the sub-specialty Bacteriology/Throat cultures. The following scores were assigned: 2020 first event = 0% [non-particpation] 2020 second event = 0% [non-participation] This is considered unsuccessful PT performance. Refer to D2021. Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- D2021 BACTERIOLOGY CFR(s): 493.823(b) Failure to participate in a testing event is unsatisfactory performance and results in a score of 0 for the testing event. Consideration may be given to those laboratories failing to participate in a testing event only if-- (1) Patient testing was suspended during the time frame allotted for testing and reporting proficiency testing results; (2) The laboratory notifies the inspecting agency and the proficiency testing program within the time frame for submitting proficiency testing results of the suspension of patient testing and the circumstances associated with failure to perform tests on proficiency testing samples; and (3) The laboratory participated in the previous two proficiency testing events. This STANDARD is not met as evidenced by: Based on PT desk review of the CMS PT data reports and PT records from the CAP PT program, the laboratory failed to participate successfully in proficiency testing for the sub-specialty Bacteriology/Throat cultures. The following scores were assigned: 2020 first event = 0% [non-particpation] 2020 second event = 0% [non-participation] This is considered unsuccessful PT performance. D6000 MODERATE COMPLEXITY LABORATORY DIRECTOR CFR(s): 493.1403 The laboratory must have a director who meets the qualification requirements of 493. 1405 of this subpart and provides overall management and direction in accordance with 493.1407 of this subpart. This CONDITION is not met as evidenced by: Based on PT desk review of the PT CMS data reports and CAP PT reports, the laboratory director failed to fulfill the laboratory director's responsibilities and ensure that the laboratory achieved a satisfactory performance and successfully participate in a PT program, for the sub-specialty Bacteriology/Throat cultures. Refer to D6016. D6016 LABORATORY DIRECTOR RESPONSIBILITIES CFR(s): 493.1407(e)(4)(i) The laboratory director is responsible for the overall operation and administration of the laboratory, including the employment of personnel who are competent to perform test procedures, and record and report test results promptly, accurate, and proficiently and for assuring compliance with the applicable regulations. (e) The laboratory director must-- (e)(4)(i) Ensure that the proficiency testing samples are tested as required under Subpart H of this part; This STANDARD is not met as evidenced by: Based on PT desk review of the PT CMS data reports and CAP PT reports, the laboratory director failed to fulfill the laboratory director's responsibilities and ensure that the laboratory achieved a satisfactory performance and successfully participate in a PT program, for the sub-specialty Bacteriology/Throat cultures. The following scores were assigned: 2020 first event = 0% [non-particpation] 2020 second event = 0% [non-participation] This is considered unsuccessful PT performance. -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access